Global Digital Therapeutic (DTx) Market Size, Trends & Growth Opportunity, By Application (Diabetes, CVD, Obesity, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), By End Use (Patients, Providers, Payers, Employers, and Others), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.

Global Digital Therapeutic (DTx) Market
Global Digital Therapeutic Market was valued at USD 4.17 billion in 2021 and is expected to reach USD 18.18 billion by 2027, at a CAGR 19.80% from 2022-2027.
Digital therapeutic is commonly called software for drugs, which delivers evidence-based therapeutic interventions to patients that are driven by high quality software programs to manage, prevent, or treat a broad spectrum of mental, physical, and behavioural conditions. This is from an independent category of evidence-based products within the broader healthcare landscape.

Market Drivers
Increasing incidences of preventable chronic diseases are considered as key driving factors which are expected to boost the global digital therapeutic market growth. Furthermore, growing emphasis on preventive healthcare will have a positive impact on market growth. 
Moreover, the rising number of venture capitalists which are investing in the market will fuel the market growth. Additionally, digital therapeutics provide easy tracking and monitoring of patients and their vital stats without invention expected to propel the market growth during this forecast period 2027.

Market Restraints
However, data safety and security are major restraining factors which are expected to hamper the global digital therapeutic (DTx) market growth. Also, lack of awareness and access to digital therapeutics programs in developing countries, and reluctance among patients to adopt digital therapeutics are some of the challenging factors which are expected to hinder the market growth.

Market Segmentation
The Global Digital Therapeutic (DTx) Market is segmented into applications such as Diabetes, CVD, Obesity, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others. 
Further, market is segmented into end Use such as Patients, Providers, Payers, Employers, and Others.

Regional Analysis
The Global Digital Therapeutic (DTx) Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region accounts for the largest market share owing to the growing geriatric population along with rising incidences of chronic disorders. Also, high healthcare expenditure, and rising demand for homecare are among key factors that contributed to the dominance of this region. 
Asia Pacific digital therapeutics market is anticipated to grow at the fastest CAGR rate.

Market Key Players
Various key players are discussed in the Global Digital Therapeutic (DTx) Market Report including: Proteus Digital Health, Omada Health, Livongo Health, Noom, Welldoc, Ginger, Propeller Health, 2morrow, Canary Health, Mango Health Inc., Akili Interactive Labs, Smartpatient gmbh, and Others.
For instance, in August 2020, Fitbit Sense, the company’s most advanced health smartwatch, bringing innovative sensor & software technology with the world’s 1st electrodermal activity sensor on a smartwatch to help manage stress, along with advanced heart rate tracking technology, a new ECG app, and an on-wrist skin temperature sensor, all powered by 6 plus days of battery life. The new product lets increase more customers and gain profits.

Market Taxonomy
By Application
•    Diabetes
•    CVD
•    Obesity
•    CNS Disease
•    Respiratory Diseases
•    Smoking Cessation
•    Others

By End Use
•    Patients
•    Providers
•    Payers
•    Employers
•    Others

By Region
•    North America
•    Latin America
•    Europe
•    Asia Pacific
•    Middle East & Africa

Global Digital Therapeutic (DTx) Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Digital Therapeutic (DTx) Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Digital Therapeutic (DTx) Market, By Application
5.1 Y-o-Y Growth Comparison, By Application 
5.2 Global Digital Therapeutic (DTx) Market Share Analysis, By Application 
5.3 Global Digital Therapeutic (DTx) Market Size and Forecast, By Application
5.3.1 Diabetes
5.3.2 CVD
5.3.3 Obesity
5.3.4 CNS Diseases
5.3.5 Respiratory Diseases
5.3.6 Smoking Cessation
5.3.7 Others
6 Global Digital Therapeutic (DTx) Market, By End Use
6.1 Y-o-Y Growth Comparison, By End Use
6.2 Global Digital Therapeutic (DTx) Market Share Analysis, By End Use
6.3 Global Digital Therapeutic (DTx) Market Size and Forecast, By End Use
6.3.1 Patients
6.3.2 Providers
6.3.3 Payers
6.3.4 Employers
6.3.5 Others
7 Global Digital Therapeutic (DTx) Market, By Region
7.1 Global Digital Therapeutic (DTx) Market Share Analysis, By Region
7.2 Global Digital Therapeutic (DTx) Market Share Analysis, By Region
7.3 Global Digital Therapeutic (DTx) Market Size and Forecast, By Region
8 North America Digital Therapeutic (DTx) Market Analysis and Forecast (2022 – 2027)
8.1 Introduction
8.2 North America Digital Therapeutic (DTx) Market Share Analysis, By Application
8.3 North America Digital Therapeutic (DTx) Market Size and Forecast, By End Use
8.4 North America Digital Therapeutic (DTx) Market Size and Forecast, By Country
8.4.1 U. S
8.4.2 Canada
8.4.3 Mexico
9 Europe Digital Therapeutic (DTx) Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Europe Digital Therapeutic (DTx) Market Share Analysis, By Application 
9.3 Europe Digital Therapeutic (DTx) Market Size and Forecast, By End Use 
9.4 Europe Digital Therapeutic (DTx) Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4 Rest of Europe
10 Asia Pacific Digital Therapeutic (DTx) Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Asia Pacific Digital Therapeutic (DTx) Market Share Analysis, By Application 
10.3 Asia Pacific Digital Therapeutic (DTx) Market Size and Forecast, By End Use 
10.4 Asia Pacific Digital Therapeutic (DTx) Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
11 Latin America Digital Therapeutic (DTx) Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Latin America Digital Therapeutic (DTx) Market Share Analysis, By Application 
11.3 Latin America Digital Therapeutic (DTx) Market Size and Forecast, By End Use 
11.4 Latin America Digital Therapeutic (DTx) Market Size and Forecast, By Country
11.4.1 Brazil
11.4.2 Rest of Latin America
12 Middle East Digital Therapeutic (DTx) Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Middle East Digital Therapeutic (DTx) Market Share Analysis, By Application 
12.3 Middle East Digital Therapeutic (DTx) Market Size and Forecast, By End Use 
12.4 Middle East Digital Therapeutic (DTx) Market Size and Forecast, By Country
12.4.1 Saudi Arabia
12.4.2 UAE
12.4.3 Egypt
12.4.4 Kuwait
12.4.5 South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 PROTEUS DIGITAL HEALTH
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 OMADA HEALTH
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 LIVONGO HEALTH
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 NOOM
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 WELLDOC
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 GINGER
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 PROPELLER HEALTH
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 2MORROW
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 CANARY HEALTH
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 MANGO HEALTH INC.
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies